Company / SG&A per Share
Arcellx, Inc. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.17
FY2025
5-year range
$1.15 / $40.63
FY2021-FY2025
Trend
+28.2%
vs FY2024
Sector context
#77 of 210
Health Care
What the data says
At $2.17, Arcellx, Inc.'s sg&a per share ranks #134 of 210 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $1.15 in FY2022 to $2.17 in FY2025.
Based on SEC 10-K filings.
2.17 in FY2025 with a 3-year CAGR of +23.7%.
Increased from $1.50 to $2.17 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 210 in Health CareTop 63% of 210This company $2.17 Sector average $40.75
▼
-94.7% below sector average
Key checks
Key Insights
- Arcellx, Inc.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 28.2% year-over-year.
- Ranks #77 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.17 | +28.2% |
| FY2024 | $1.69 | +12.4% |
| FY2023 | $1.50 | +31.1% |
| FY2022 | $1.15 | -97.2% |
| FY2021 | $40.63 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026